>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
胃癌患者血清Linc00659水平变化及其临床意义
作者:单万硕1  杨晶2  张亚和1 
单位:1. 万宁市人民医院消化内科, 海南 万宁 571500;
2. 万宁市人民医院肿瘤内科, 海南 万宁 571500
关键词:Linc00659 胃癌 诊断 生物信息学 生物标志物 
分类号:R753.2
出版年·卷·期(页码):2022·41·第四期(525-532)
摘要:

目的:分析胃癌患者血清Linc00659水平变化及其临床意义。方法:收集癌症基因组图谱(TCGA)数据库中胃癌患者的肿瘤样本(n=408)和正常样本(n=36)中Linc00659表达数据,利用Kaplan-Meier曲线评估其与生存之间的关系。采用基因集富集分析(GSEA)阐释Linc00659的生物学功能。收集2017年12月至2020年9月在我院就诊的226例胃癌、67例癌前病变、70例胃良性病变患者和45例健康对照者的基线血清样本。血清Linc00659由无法获知患者信息的独立研究人员通过实时荧光定量聚合酶链反应(qRT-PCR)进行测定。使用受试者工作特征(ROC)曲线计算其诊断效率。结果:基于TCGA数据库信息,Linc00659在胃癌组织中的表达显著上调,且血清Linc00659水平升高与晚期胃癌(P=0.022)和不良预后(P=0.040)相关。使用生物信息学方法进一步分析显示,上皮细胞迁移和上皮间充质转化途径可能是Linc00659促进胃癌进展的假定分子机制。在临床样本实验中,胃癌组患者血清Linc00659水平均高于其他3组(P<0.05),经ROC曲线分析,血清Linc00659用于胃癌诊断以及区分胃癌和癌前病变患者的AUC为0.841(95%CI 0.800~0.882)、0.797(95%CI 0.739~0.855)。在临床病理特征中,pT分期(P=0.033)、pTNM分期(P=0.036)、血管侵犯(P=0.001)、微卫星不稳定性(MSI)(P=0.004)与血清Linc00659基线水平相关。结论:血清Linc00659有望成为胃癌诊断和恶性进展的一个重要分子标志物。

Objective: To analyze the changes and clinical significance of serum Linc00659 level in patients with gastric cancer. Methods: The expression levels of Linc00659 in gastric cancer samples (n=408) and normal samples (n=36) in The Cancer Genome Atlas (TCGA) database were collected, and the relationship between Linc00659 and survival was evaluated by Kaplan-Meier curve. Gene set enrichment analysis (GSEA) was performed to annotate the biological function of Linc00659. Baseline serum samples were collected from 226 patients with gastric cancer, 67 patients with precancerous lesions, 70 patients with benign gastric lesions and 45 healthy controls from December 2017 to September 2020. Serum Linc00659 was measured by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) by independent researchers who were unable to obtain patients information. The diagnostic efficiency was calculated using the receiver operating characteristic (ROC) curve. Results: Based on TCGA database information, the expression of Linc00659 in gastric cancer was significantly up-regulated, and the elevated level of serum Linc00659 was associated with advanced gastric cancer (P=0.022) and poor prognosis (P=0.040). Further analysis using bioinformatics methods showed that epithelial cell migration and epithelial mesenchymal transformation pathway may be the hypothetical molecular mechanism of Linc00659 promoting the progression of gastric cancer. In the clinical sample experiment, the level of serum Linc00659 in the gastric cancer group was higher than those in the other three groups (P<0.05). The AUC of serum Linc00659 for the diagnosis of gastric cancer and the differentiation between gastric cancer and precancerous lesions was 0.841 (95% CI 0.800-0.882) and 0.797 (95% CI 0.739-0.855). Among the clinicopathological features, pT stage (P=0.033), pTNM stage (P=0.036), vascular invasion (P=0.001) and microsatellite instability (MSI) (P=0.004) were associated with the baseline level of serum Linc00659. Conclusion: Serum Linc00659 is expected to become an important molecular marker in the diagnosis and malignant progression of gastric cancer.

参考文献:

[1] 林煜展, 朱钱迎.血清学指标检测在胃癌诊断中的研究进展[J].检验医学与临床, 2022, 19(7):985-987.
[2] 王思琪, 唐明, 王梁华, 等."泛癌症图谱"的解读及应用[J].生命的化学, 2020, 40(5):684-691.
[3] 彭雪辉, 苏纳, 李宗桃, 等.中国染色体蛋白质组计划研究进展[J].生命科学, 2016, 28(9):1054-1066.
[4] SNIJDERS A M, MAO J H.Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types[J].Adv Mod Oncol Res, 2016, 2(4):215-223.
[5] ALI M W, PATRO C P K, ZHU J J, et al.A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes[J].Hum Mutat, 2021, 42(1):77-88.
[6] LI Q, ZHANG D, WANG H, et al.SLCO4A1-AS1 facilitates the malignant phenotype via miR-149-5p/STAT3 axis in gastric cancer cells[J].J Oncol, 2021, 2021:1698771.
[7] CORRÊA T, VENÂNCIO A C, GALERA M F, et al.Candidate genes associated with delayed neuropsychomotor development and seizures in a patient with ring chromosome 20[J].Case Rep Genet, 2020, 2020:5957415.
[8] TSOUKALAS N, TSAPAKIDIS K, KAMPOSIORAS K.AJCC-8 TNM staging system for gastric cancer.Is there a scope for improvement?[J].J Invest Surg, 2020, 33(10):939-940.
[9] 林晨, 张再重, 王烈.美国国家综合癌症网络临床实践指南:胃癌(2020V2)更新要点和解读[J].临床外科杂志, 2021, 29(1):23-25.
[10] 杨永红, 张宇杰, 林明春, 等.胃癌血清蛋白标记物的筛选及鉴定[J].基因组学与应用生物学, 2018, 37(9):4208-4213.
[11] 付非非, 刘志利, 沈冬, 等.基因间长链非编码RNA 00511促进人胃癌细胞增殖的实验研究[J].胃肠病学和肝病学杂志, 2020, 29(10):1098-1102, 1108.
[12] 李超, 耿艳芳, 洪展桐.整合生物信息学挖掘胃癌潜在关键生物标志物[J].现代肿瘤医学, 2022, 30(3):476-480.
[13] 常紫薇, 刘辉, 张秋萌, 等.基于TCGA和LASSO回归的胃癌预后lncRNA预测模型构建[J].临床肿瘤学杂志, 2020, 25(9):823-829.
[14] 季凯月, 张天祺, 张梦圆, 等.与胃癌侵袭和转移相关的lncRNA研究[J].胃肠病学和肝病学杂志, 2021, 30(6):601-605.
[15] TABACH Y, KOGAN-SAKIN I, BUGANIM Y, et al.Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer[J].PLoS One, 2011, 6(1):e14632.
[16] VOUTSADAKIS I A.Chromosome 20q11.21 amplifications in colorectal cancer[J].Cancer Genomics Proteomics, 2021, 18(3 Suppl):487-496.
[17] ZHANG B, YAO K, ZHOU E, et al.Chr20q amplification defines a distinct molecular subtype of microsatellite stable colorectal cancer[J].Cancer Res, 2021, 81(8):1977-1987.
[18] LANE S W.Inflammation in del(20q):a MST opportunity[J].Blood, 2019, 134(20):1685-1686.
[19] PTASHKIN R N, PAGAN C, YAEGER R, et al.Chromosome 20q amplification defines a subtype of microsatellite stable, left-sided colon cancers with wild-type RAS/RAF and better overall survival[J].Mol Cancer Res, 2017, 15(6):708-713.
[20] ZHOU L, LI J, TANG Y, et al.Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis[J].J Transl Med, 2021, 19(1):8-31.
[21] SHENG Y, HAN C, YANG Y, et al.Correlation between LncRNA-LINC00659 and clinical prognosis in gastric cancer and study on its biological mechanism[J].J Cell Mol Med, 2020, 24(24):14467-14480.
[22] GONG P, XU Y, LIU M, et al.Upregulation of LINC00659 expression predicts a poor prognosis and promotes migration and invasion of gastric cancer cells[J].Oncol Lett, 2021, 22(1):557-565.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 413796 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364